Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian D Sanders

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Clinical Trials (London, England)|December 16, 2006
Cost-effectiveness as an outcome in randomized clinical trialsMark A Hlatky, Douglas K Owens, Gillian D Sanders
Emerging Infectious Diseases|November 20, 2004
Evaluating human papillomavirus vaccination programsAl V Taira, Christopher P Neukermans, Gillian D Sanders
The New England Journal of Medicine|October 7, 2005
Cost-effectiveness of implantable cardioverter-defibrillatorsGillian D Sanders, Mark A Hlatky, Douglas K Owens
Archives of Internal Medicine|January 11, 2007
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolismDaniella J Perlroth, Gillian D Sanders, Michael K Gould
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
JAMA Cardiology|October 5, 2017
Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-ReplySana M Al-Khatib, Gregg C Fonarow, Gillian D Sanders
Cardiac Electrophysiology Clinics|February 12, 2018
When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?Sana M Al-Khatib, Daniel J Friedman, Gillian D Sanders
Annals of Internal Medicine|June 19, 2008
Cost-effectiveness of HIV screening in patients older than 55 years of ageGillian D Sanders, Ahmed M Bayoumi, Mark Holodniy, et al.
European Journal of Endocrinology|May 29, 2008
Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysisChrysoula Dosiou, Gillian D Sanders, Sally S Araki, et al.
Gynecologic Oncology|August 30, 2008
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?Laura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Clinical Trials (London, England)|December 16, 2006
Cost-effectiveness as an outcome in randomized clinical trialsMark A Hlatky, Douglas K Owens, Gillian D Sanders
Emerging Infectious Diseases|November 20, 2004
Evaluating human papillomavirus vaccination programsAl V Taira, Christopher P Neukermans, Gillian D Sanders
The New England Journal of Medicine|October 7, 2005
Cost-effectiveness of implantable cardioverter-defibrillatorsGillian D Sanders, Mark A Hlatky, Douglas K Owens
Archives of Internal Medicine|January 11, 2007
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolismDaniella J Perlroth, Gillian D Sanders, Michael K Gould
JAMA|December 29, 2016
Updated Recommendations for Cost-effectiveness Studies-ReplyGillian D Sanders, Peter J Neumann, Louise B Russell
JAMA Cardiology|October 5, 2017
Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-ReplySana M Al-Khatib, Gregg C Fonarow, Gillian D Sanders
Cardiac Electrophysiology Clinics|February 12, 2018
When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?Sana M Al-Khatib, Daniel J Friedman, Gillian D Sanders
Annals of Internal Medicine|June 19, 2008
Cost-effectiveness of HIV screening in patients older than 55 years of ageGillian D Sanders, Ahmed M Bayoumi, Mark Holodniy, et al.
European Journal of Endocrinology|May 29, 2008
Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysisChrysoula Dosiou, Gillian D Sanders, Sally S Araki, et al.
Gynecologic Oncology|August 30, 2008
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?Laura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, et al.
Pageof 15